Cyanobacteria and eukaryotic microalgae as potential sources of antibiotics
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
:Bacterial resistance to antibiotics is an issue receiving significant attention and highlights the urgent need for new classes of antibiotics. This has led to exploration for natural compounds from relatively unexplored microorganisms including microalgae. These photosynthetic organisms are extremely diverse and ubiquitous and have been shown to produce compounds that exhibit antibacterial activity against human pathogens. Their ability to survive in a wide range of environmental conditions and the possibility of culture condition manipulation for optimization of antibacterial compounds suggests that they have significant potential. However, only a few species have been so far investigated, and very few metabolites characterized. This review provides an overview of this research and illustrates the opportunity for significantly more systematic investigation of these microorganisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valuable Products from Biotechnology of Microalgae
Pulz, O., & Gross, W. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1647-x · Cited by 2,132 · cited 1×
“This is likely due in part to the paucity of information regarding activity and toxicity in vivo (Borowitzka 1995), as well as the challenges of controlled large-scale production (Skulberg 2000; Olaizola 2003; Pulz & Gross 2004; Wijffels 2008; Skjånes et al. 2013).”
BackgroundHigh-value products from microalgae—their development and commercialisation
Borowitzka, M. A. (2013) · Journal of Applied Phycology · doi:10.1007/s10811-013-9983-9 · Cited by 1,585
Handbook of Microalgal Culture: Applied Phycology and Biotechnology
(2013) · doi:10.1002/9781118567166 · Cited by 979
Marine cyanobacteria—a prolific source of natural products
Burja, A. M., Banaigs, B., Abou-Mansour, E., Grant Burgess, J., & Wright, P. C. (2001) · Tetrahedron · doi:10.1016/s0040-4020(01)00931-0 · Cited by 841
Juneja, A., Ceballos, R., & Murthy, G. (2013) · Energies · doi:10.3390/en6094607 · Cited by 835
Applications of cyanobacteria in biotechnology
Abed, R. M. M., Dobretsov, S., & Sudesh, K. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03918.x · Cited by 528 · cited 1×
“Some purified compounds have promising commercial applications as bioplastics, biofertilizers, antiviral, antifungal, anticancer and antibacterial drugs (Patterson et al. 1994; Abed et al. 2009; Leão et al. 2013).”
BackgroundMicroalgae as sources of pharmaceuticals and other biologically active compounds
Borowitzka, M. A. (1995) · Journal of Applied Phycology · doi:10.1007/bf00003544 · Cited by 520 · cited 8×
“This is likely due in part to the paucity of information regarding activity and toxicity in vivo (Borowitzka 1995), as well as the challenges of controlled large-scale production (Skulberg 2000; Olaizola 2003; Pulz & Gross 2004; Wijffels 2008; Skjånes et al. 2013).”
BackgroundInfluentialCyanobacteria: an emerging source for drug discovery
Singh, R. K., Tiwari, S. P., Rai, A. K., & Mohapatra, T. M. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.21 · Cited by 370
Breuer, G., Lamers, P. P., Martens, D. E., Draaisma, R. B., & Wijffels, R. H. (2013) · Bioresource Technology · doi:10.1016/j.biortech.2013.05.105 · Cited by 270
Volk, R.-B., & Furkert, F. H. (2006) · Microbiological Research · doi:10.1016/j.micres.2005.08.005 · Cited by 247 · cited 2×
“Cyanobacteria have been the major investigated photosynthetic microorganisms (Bloor & England 1989; Jaki et al. 1999; Ghasemi et al. 2003, 2004; Soltani et al. 2005; Volk & Furkert 2006; Parisi et al. 2009; Kumar et al. 2011).”
Background
Cited by
Extraction and fractionation of microalgae-based protein products
Soto-Sierra, L., Stoykova, P., & Nikolov, Z. L. (2018) · Algal Research · doi:10.1016/j.algal.2018.10.023 · Cited by 286
Something old, something new: revisiting natural products in antibiotic drug discovery
Wright, G. D. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0063 · Cited by 283
Bioactive food compounds from microalgae: an innovative framework on industrial biorefineries
Jacob-Lopes, E., Maroneze, M. M., Deprá, M. C., Sartori, R. B., Dias, R. R., & Zepka, L. Q. (2019) · Current Opinion in Food Science · doi:10.1016/j.cofs.2018.12.003 · Cited by 255
Bioactive substances and potentiality of marine microalgae
Wu, J., Gu, X., Yang, D., Xu, S., Wang, S., Chen, X., & Wang, Z. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2471 · Cited by 118
“Now multiple studies have shown that short- chain fatty acids and unsaturated chain fatty acids isolated from microalgae had antibacterial activity (Falaise et al., 2016; Senhorinho et al., 2015).”
BackgroundTetraedron minimum, First Reported Member of Hydrodictyaceae to Accumulate Secondary Carotenoids
Doppler, P., Kornpointner, C., Halbwirth, H., Remias, D., & Spadiut, O. (2021) · Life · doi:10.3390/life11020107 · Cited by 17
“The generated biomass is a sustainable, literally green alternative for the production of various value-added compounds for biofuels [1], for health and nutrition [2], for pharmaceuticals [3], and other bioactive molecules, such as antibiotics [4].”
Background
Metadata
- Authors
- Senhorinho, G. N. A., Ross, G. M., & Scott, J. A.
- Venue
- Phycologia
- Publisher
- Informa UK Limited
- Published
- 2015-05
- Volume
- 54
- Issue
- 3
- Pages
- 271-282
- ISSN
- 0031-8884 (ISSN-L)
- 2330-2968
- OpenAlex
- W2124861647
- Cited by
- 56
- References
- 12
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.